Inventor
RAY SANGEETA
US26 patents
⚠️ This page may combine multiple inventors who share the name “RAY SANGEETA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV JOHNS HOPKINS
24 patentsUS9776977B2Oct 3, 2017
PSMA-targeting compounds and uses thereof
UNIV JOHNS HOPKINS14 citations92
US9694091B2Jul 4, 2017
Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
UNIV JOHNS HOPKINS19 citations91
US9884132B2Feb 6, 2018
Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
UNIV JOHNS HOPKINS9 citations83
US10039845B2Aug 7, 2018
Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
UNIV JOHNS HOPKINS7 citations82
US9371360B2Jun 21, 2016
Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
UNIV JOHNS HOPKINS12 citations82
US11661402B2May 30, 2023
PSMA-targeting compounds and uses thereof
UNIV JOHNS HOPKINS3 citations73
US11021450B2Jun 1, 2021
PSMA targeted fluorescent agents for image guided surgery
UNIV JOHNS HOPKINS4 citations73
US10736974B2Aug 11, 2020
Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy
UNIV JOHNS HOPKINS4 citations73
US10717750B2Jul 21, 2020
68Ga-labeled NOTA-chelated PSMA-targeted imaging and therapeutic agents
UNIV JOHNS HOPKINS4 citations73
US10688198B2Jun 23, 2020
Salicylic acid-based polymeric CEST contrast agents targeting prostate-specific membrane antigen and uses thereof
UNIV JOHNS HOPKINS4 citations72
US10653806B2May 19, 2020
Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
UNIV JOHNS HOPKINS4 citations72
US10188754B2Jan 29, 2019
Compositions and methods for chemical exchange saturation transfer (CEST) based magnetic resonance imaging (MRI)
UNIV JOHNS HOPKINS4 citations72
US11813340B2Nov 14, 2023
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy
UNIV JOHNS HOPKINS2 citations71
US10683272B2Jun 16, 2020
Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy
UNIV JOHNS HOPKINS5 citations71
US10369113B2Aug 6, 2019
Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer
UNIV JOHNS HOPKINS4 citations71
US12065413B2Aug 20, 2024
PSMA targeted fluorescent agents for image guided surgery
UNIV JOHNS HOPKINS0 citations62
US11911488B2Feb 27, 2024
Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy
UNIV JOHNS HOPKINS0 citations62
US11814365B2Nov 14, 2023
PSMA targeted fluorescent agents for image guided surgery
UNIV JOHNS HOPKINS0 citations62
US11478558B2Oct 25, 2022
Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer
UNIV JOHNS HOPKINS1 citations62
US11458213B2Oct 4, 2022
Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer
UNIV JOHNS HOPKINS1 citations62
US11078166B2Aug 3, 2021
Triazole conjugated ureas, thioureas, carbamates, and reversed carbamates for PSMA-targeted imaging agents and uses thereof
UNIV JOHNS HOPKINS0 citations62
US12233137B1Feb 25, 2025
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy
UNIV JOHNS HOPKINS0 citations60
US11871895B2Jan 16, 2024
Raman spectroscopy reporters and methods for molecular imaging of tissue in vivo
UNIV JOHNS HOPKINS0 citations60
US10857246B2Dec 8, 2020
Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase IX and uses thereof
UNIV JOHNS HOPKINS0 citations39